IL-17 Inhibition: A Valid Therapeutic Strategy in the Management of Hidradenitis Suppurativa

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with a significant negative impact on the quality of life of patients. To date, the therapeutic landscape for the management of the disease has been extremely limited, resulting in a profound unmet need. Indeed, adalimumab, an anti...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pharmaceutics Jg. 15; H. 10; S. 2450
Hauptverfasser:	Malvaso, Dalma, Calabrese, Laura, Chiricozzi, Andrea, Antonelli, Flaminia, Coscarella, Giulia, Rubegni, Pietro, Peris, Ketty
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Basel MDPI AG 01.10.2023 MDPI
Schlagworte:	bimekizumab biologics brodalumab Chemokines Cytokines Disease Health aspects hidradenitis suppurativa IL-17 inhibitors Inflammation Localization Metabolic syndrome Monoclonal antibodies Neutrophils Pathogenesis Pathophysiology Psoriasis Review secukinumab Skin Skin diseases Tumor necrosis factor Tumor necrosis factor-TNF
ISSN:	1999-4923, 1999-4923
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!